Under construction – not a live service
Sign in
Taking people in SwedenPhase 2

Tests Salovum and SPC flakes for swelling caused by brain tumors

Tests egg yolk powder and oat flakes in adults with brain tumor swelling.

Plain-language title generated from the registry record
Registry title: Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

Key facts

Where
Lund, SwedenSee the site
Phase
Phase 2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 79 years old?

Source: NCT06710249, who can take part

Where in Sweden

  • Department of NeurosurgeryLund, SwedenTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Peter Siesjö
Trial code
NCT06710249
Record updated
27 January 2025
Original description
The objective of this clinical trial is to explore the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, and SPC® flakes , hydrothermically processed oats, on cerebral edema with clinical symptoms in participants with brain tumors.Read full original descriptionShow less

Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

The objective of this clinical trial is to explore the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, and SPC® flakes , hydrothermically processed oats, on cerebral edema with clinical symptoms in participants with brain tumors.

The primary questions the trial seeks to answer are:

* Can Salovum® and SPC® flakes have effect on clinical symptoms of tumor-induced cerebral edema? * Can Salovum® and SPC® flakes induce regression of radiological edema in tumor-induced cerebral edema Additionally, the study will investigate the impact of Salovum® and SPC® flakes in steroid refractory, steroid naïve cerebral edema and type of barin tumor

Researchers will:

Evaluate edema change from baseline by MRI after 14 days Evaluate neurological and cognitive symptoms Register dose of steroid medications

Participants will:

* Ingest Salovum® 11g three times daily for 14 days, thereafter tapered during 14 days * Ingest SPC® flakes 1g/kg daily from day 7

Inclusion: Age 18-79 years; Known or radiologically suspected primary or secondary brain tumor (suspected metastasis, meningioma, glioma, etc.) with surrounding edema causing clinical signs; GCS 14-15; WHO ECOG performance status 0-2; Planned or started cortisone treatment; Ability to provide informed consent.

Exclusion: Egg yolk allergy; Epilepsy as sole symptom from the cerebral edema; Midline shift >5mm; GCS ≤13.

ClinicalTrials.gov NCT06710249